Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
2.360
-0.170 (-6.72%)
At close: Aug 7, 2025, 4:00 PM
2.370
+0.010 (0.43%)
Pre-market: Aug 8, 2025, 8:00 AM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $167.94 million as of August 8, 2025. Its market cap has decreased by -17.28% in one year.
Market Cap
167.94M
Enterprise Value
-50.32M
1-Year Change
-17.28%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $167.94M, a decrease of -78.55%. That is a compound annual growth rate of -33.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 167.94M | 8.45% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
| Oct 21, 2021 | 782.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| UnitedHealth Group | 221.95B |
| Novartis AG | 221.76B |
| Novo Nordisk | 213.92B |